GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Liver Transplantation/Post-Transplant Infections Drive Early Readmissions : Liver Transpl | Apr 2026

Post-Transplant Infections Drive Early Readmissions : Liver Transpl | Apr 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated June 1, 2026

Quick Answer

Introduction: Hospital readmission within 30 days of liver transplantation is a common and costly event that reflects early postoperative morbidity and is increasingly used as a quality metric in transplant care. Early readmissions place substantial burdens on patients and healthcare systems and have been associated with worse long-term outcomes.


Introduction:

Hospital readmission within 30 days of liver transplantation is a common and costly event that reflects early postoperative morbidity and is increasingly used as a quality metric in transplant care. Early readmissions place substantial burdens on patients and healthcare systems and have been associated with worse long-term outcomes. However, predictors of readmission have varied across studies, limiting the development of effective preventive strategies.

Problem Statement:

Most previous studies examining post-transplant readmissions have been limited by single-center experience or administrative datasets, making it difficult to identify consistent and actionable risk factors. Understanding the causes and predictors of early readmission is essential for improving post-transplant care and reducing avoidable healthcare utilization.

Summary:

Using the national TransQIP registry, this study evaluated patterns and determinants of unplanned 30-day readmission after deceased donor liver transplantation. The investigators found that early readmission was common, affecting more than two-fifths of transplant recipients. Most readmissions were relatively short and were not primarily driven by procedural complications, suggesting that medical issues remain the dominant cause of rehospitalization during the early post-transplant period. The most important finding was the strong association between post-discharge infectious complications and readmission risk. Organ-space surgical site infections emerged as the strongest predictor, followed by sepsis and urinary tract infections. These observations highlight infection prevention, early detection, and prompt outpatient management as critical targets for reducing readmissions after liver transplantation. In contrast, better pre-existing functional status was independently associated with a lower likelihood of readmission, emphasizing the importance of patient conditioning and functional recovery. The study also identified distinct risk profiles for different infection types, suggesting opportunities for more personalized post-discharge monitoring strategies. Overall, these findings indicate that many early readmissions may be preventable through focused infection surveillance, optimized discharge planning, and enhanced outpatient follow-up. The results provide important national-level evidence supporting targeted interventions aimed at reducing infectious complications and improving early outcomes after liver transplantation.

Related Q&A

Synbiotics After Liver Transplant Show No Clinical Benefit: Liver Transplant | July 2026

Introduction: Bacterial infections remain a major cause of morbidity after liver transplantation despite advances in perioperative care. Synbiotics, combining probiotics and prebiotics, have been proposed to reduce postoperative infections by restoring gut microbiota and strengthening...

Tranexamic Acid in Liver Transplantation: Liver Transplant | June 2026

Introduction: Perioperative bleeding remains a major challenge during orthotopic liver transplantation (OLT), largely due to hyperfibrinolysis and coagulation abnormalities. Although tranexamic acid (TXA) effectively reduces bleeding in several surgical settings, its routine prophylactic use during...

Whole-Organ Donor Liver Assessment Using PS-OCT: Science Translational Medicine | July 2026

Introduction: Liver transplantation is limited by a shortage of suitable donor organs. Current viability assessment relies on needle biopsy, which samples only a small portion of the liver and may miss important regional pathology. This...

Personalizing Antifibrinolytic Use in Liver Transplantation : Liver Transpl | Jul 2026

Introduction: Bleeding remains a major challenge during liver transplantation despite advances in surgical techniques, anesthesia, and perioperative care. Antifibrinolytic agents have long been used to reduce intraoperative blood loss and transfusion requirements. However, evolving transplant...

Integrating LDLT into Modern Liver Transplant Programs: Liver Transplantation | June 2026

Introduction: The demand for liver transplantation continues to exceed the availability of deceased donor organs, resulting in prolonged waiting times and preventable waitlist mortality. This perspective discusses how living donor liver transplantation (LDLT) can complement...

Post-Transplant Management in Pediatric LT: Liver Transplantation | June 2026

Introduction: Pediatric liver transplantation has achieved excellent survival rates, shifting the focus from graft survival alone to optimising long-term health, growth, neurodevelopment, and quality of life. This updated guideline provides evidence-based recommendations for comprehensive care...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer